Scientists test if new flu drug plays nice with your annual shot
NCT ID NCT07300085
Summary
This study is checking if it's safe to give a new, long-acting flu prevention medicine called CD388 at the same time as a high-dose flu vaccine. Researchers want to see if the drug interferes with the body's ability to build protection from the vaccine. About 100 healthy adults will get either the vaccine with the drug or the vaccine with a placebo, and their immune response and any side effects will be closely monitored.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
California Clinical Trials Medical Group (CCTMG) managed by Parexel
Glendale, California, 91206, United States
-
Parexel International - EPCU Baltimore
Baltimore, Maryland, 21225, United States
Conditions
Explore the condition pages connected to this study.